Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial

BACKGROUND Intestinal mast cells may cause gastrointestinal symptoms in patients with diarrhea-dominant irritable bowel syndrome (IBS). The objective of this study was to determine the effect of mesalazine on the number of lamina propria mast cells and clinical manifestations of patients with diarrh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Middle East J Dig Dis
Main Authors: Ghadir, Mohammad Reza, Poradineh, Mehri, Sotodeh, Masoud, Ansari, Reza, Kolahdoozan, Shadi, Hormati, Ahmad, Yousefi, Mohammad Hosein, Mirzaei, Samaneh, Vahedi, Homayoon
Formato: Artigo
Idioma:Inglês
Publicado em: Iranian Association of Gastroerterology and Hepatology 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308130/
https://ncbi.nlm.nih.gov/pubmed/28316762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/mejdd.2016.47
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados